Especially in patients with slightly elevated PSA, conventional imaging methods show that prostate tumor lesions are insufficient, and the advantages of prostate targeted puncture combined with PSMA PET/CT images are more obvious. The gene discussed is FOLH1; the disease is prostate neoplasm.